Skip to main content
Advertisement
  • Neurology.org
  • Journals
    • Neurology
    • Clinical Practice
    • Education
    • Genetics
    • Neuroimmunology & Neuroinflammation
  • Online Sections
    • Neurology Video Journal Club
    • Diversity, Equity, & Inclusion (DEI)
    • Neurology: Clinical Practice Accelerator
    • Practice Buzz
    • Practice Current
    • Residents & Fellows
    • Without Borders
  • Collections
    • COVID-19
    • Disputes & Debates
    • Health Disparities
    • Infographics
    • Neurology Future Forecasting Series
    • Null Hypothesis
    • Patient Pages
    • Topics A-Z
    • Translations
    • UDDA Revision Series
  • Podcast
  • CME
  • About
    • About the Journals
    • Contact Us
    • Editorial Board
  • Authors
    • Submit New Manuscript
    • Submit Revised Manuscript
    • Author Center

Advanced Search

Main menu

  • Neurology.org
  • Journals
    • Neurology
    • Clinical Practice
    • Education
    • Genetics
    • Neuroimmunology & Neuroinflammation
  • Online Sections
    • Neurology Video Journal Club
    • Diversity, Equity, & Inclusion (DEI)
    • Neurology: Clinical Practice Accelerator
    • Practice Buzz
    • Practice Current
    • Residents & Fellows
    • Without Borders
  • Collections
    • COVID-19
    • Disputes & Debates
    • Health Disparities
    • Infographics
    • Neurology Future Forecasting Series
    • Null Hypothesis
    • Patient Pages
    • Topics A-Z
    • Translations
    • UDDA Revision Series
  • Podcast
  • CME
  • About
    • About the Journals
    • Contact Us
    • Editorial Board
  • Authors
    • Submit New Manuscript
    • Submit Revised Manuscript
    • Author Center
  • Home
  • Latest Articles
  • Current Issue
  • Past Issues
  • Neurology Video Journal Club
  • Residents & Fellows

User menu

  • Subscribe
  • My Alerts
  • Log in

Search

  • Advanced search
Neurology
Home
The most widely read and highly cited peer-reviewed neurology journal
  • Subscribe
  • My Alerts
  • Log in
Site Logo
  • Home
  • Latest Articles
  • Current Issue
  • Past Issues
  • Neurology Video Journal Club
  • Residents & Fellows

Share

September 09, 2003; 61 (5) Brief Communications

[11C](R)-PK11195 PET imaging of microglial activation in multiple system atrophy

A. Gerhard, R. B. Banati, G. B. Goerres, A. Cagnin, R. Myers, R. N. Gunn, F. Turkheimer, C. D. Good, C. J. Mathias, N. Quinn, J. Schwarz, D. J. Brooks
First published September 8, 2003, DOI: https://doi.org/10.1212/01.WNL.0000078192.95645.E6
A. Gerhard
From MRC Clinical Sciences Center and Division of Neuroscience (Drs. Gerhard, Banati, Goerres, Cagnin, Myers, Gunn, Turkheimer, Mathias, and Brooks), Faculty of Medicine, Imperial College, London, UK; Division of Nuclear Medicine (Dr. Goerres), University of Zürich, Switzerland; Department of Neurology and Psychiatry (Dr. Cagnin), University of Padua, Italy; Imaging Research Solutions Ltd. (Drs. Myers, Turkheimer, and Brooks), Hammersmith Hospital, London, UK; McConnell Brain Imaging Center (Dr. Gunn), Montreal Neurological Institute, Montreal, Canada; Institute of Neurology (Drs. Good, Mathias, and Quinn), Queen Square, London, UK; and Department of Neurology (Dr. Schwarz), University of Leipzig, Germany.
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
R. B. Banati
From MRC Clinical Sciences Center and Division of Neuroscience (Drs. Gerhard, Banati, Goerres, Cagnin, Myers, Gunn, Turkheimer, Mathias, and Brooks), Faculty of Medicine, Imperial College, London, UK; Division of Nuclear Medicine (Dr. Goerres), University of Zürich, Switzerland; Department of Neurology and Psychiatry (Dr. Cagnin), University of Padua, Italy; Imaging Research Solutions Ltd. (Drs. Myers, Turkheimer, and Brooks), Hammersmith Hospital, London, UK; McConnell Brain Imaging Center (Dr. Gunn), Montreal Neurological Institute, Montreal, Canada; Institute of Neurology (Drs. Good, Mathias, and Quinn), Queen Square, London, UK; and Department of Neurology (Dr. Schwarz), University of Leipzig, Germany.
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
G. B. Goerres
From MRC Clinical Sciences Center and Division of Neuroscience (Drs. Gerhard, Banati, Goerres, Cagnin, Myers, Gunn, Turkheimer, Mathias, and Brooks), Faculty of Medicine, Imperial College, London, UK; Division of Nuclear Medicine (Dr. Goerres), University of Zürich, Switzerland; Department of Neurology and Psychiatry (Dr. Cagnin), University of Padua, Italy; Imaging Research Solutions Ltd. (Drs. Myers, Turkheimer, and Brooks), Hammersmith Hospital, London, UK; McConnell Brain Imaging Center (Dr. Gunn), Montreal Neurological Institute, Montreal, Canada; Institute of Neurology (Drs. Good, Mathias, and Quinn), Queen Square, London, UK; and Department of Neurology (Dr. Schwarz), University of Leipzig, Germany.
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
A. Cagnin
From MRC Clinical Sciences Center and Division of Neuroscience (Drs. Gerhard, Banati, Goerres, Cagnin, Myers, Gunn, Turkheimer, Mathias, and Brooks), Faculty of Medicine, Imperial College, London, UK; Division of Nuclear Medicine (Dr. Goerres), University of Zürich, Switzerland; Department of Neurology and Psychiatry (Dr. Cagnin), University of Padua, Italy; Imaging Research Solutions Ltd. (Drs. Myers, Turkheimer, and Brooks), Hammersmith Hospital, London, UK; McConnell Brain Imaging Center (Dr. Gunn), Montreal Neurological Institute, Montreal, Canada; Institute of Neurology (Drs. Good, Mathias, and Quinn), Queen Square, London, UK; and Department of Neurology (Dr. Schwarz), University of Leipzig, Germany.
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
R. Myers
From MRC Clinical Sciences Center and Division of Neuroscience (Drs. Gerhard, Banati, Goerres, Cagnin, Myers, Gunn, Turkheimer, Mathias, and Brooks), Faculty of Medicine, Imperial College, London, UK; Division of Nuclear Medicine (Dr. Goerres), University of Zürich, Switzerland; Department of Neurology and Psychiatry (Dr. Cagnin), University of Padua, Italy; Imaging Research Solutions Ltd. (Drs. Myers, Turkheimer, and Brooks), Hammersmith Hospital, London, UK; McConnell Brain Imaging Center (Dr. Gunn), Montreal Neurological Institute, Montreal, Canada; Institute of Neurology (Drs. Good, Mathias, and Quinn), Queen Square, London, UK; and Department of Neurology (Dr. Schwarz), University of Leipzig, Germany.
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
R. N. Gunn
From MRC Clinical Sciences Center and Division of Neuroscience (Drs. Gerhard, Banati, Goerres, Cagnin, Myers, Gunn, Turkheimer, Mathias, and Brooks), Faculty of Medicine, Imperial College, London, UK; Division of Nuclear Medicine (Dr. Goerres), University of Zürich, Switzerland; Department of Neurology and Psychiatry (Dr. Cagnin), University of Padua, Italy; Imaging Research Solutions Ltd. (Drs. Myers, Turkheimer, and Brooks), Hammersmith Hospital, London, UK; McConnell Brain Imaging Center (Dr. Gunn), Montreal Neurological Institute, Montreal, Canada; Institute of Neurology (Drs. Good, Mathias, and Quinn), Queen Square, London, UK; and Department of Neurology (Dr. Schwarz), University of Leipzig, Germany.
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
F. Turkheimer
From MRC Clinical Sciences Center and Division of Neuroscience (Drs. Gerhard, Banati, Goerres, Cagnin, Myers, Gunn, Turkheimer, Mathias, and Brooks), Faculty of Medicine, Imperial College, London, UK; Division of Nuclear Medicine (Dr. Goerres), University of Zürich, Switzerland; Department of Neurology and Psychiatry (Dr. Cagnin), University of Padua, Italy; Imaging Research Solutions Ltd. (Drs. Myers, Turkheimer, and Brooks), Hammersmith Hospital, London, UK; McConnell Brain Imaging Center (Dr. Gunn), Montreal Neurological Institute, Montreal, Canada; Institute of Neurology (Drs. Good, Mathias, and Quinn), Queen Square, London, UK; and Department of Neurology (Dr. Schwarz), University of Leipzig, Germany.
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
C. D. Good
From MRC Clinical Sciences Center and Division of Neuroscience (Drs. Gerhard, Banati, Goerres, Cagnin, Myers, Gunn, Turkheimer, Mathias, and Brooks), Faculty of Medicine, Imperial College, London, UK; Division of Nuclear Medicine (Dr. Goerres), University of Zürich, Switzerland; Department of Neurology and Psychiatry (Dr. Cagnin), University of Padua, Italy; Imaging Research Solutions Ltd. (Drs. Myers, Turkheimer, and Brooks), Hammersmith Hospital, London, UK; McConnell Brain Imaging Center (Dr. Gunn), Montreal Neurological Institute, Montreal, Canada; Institute of Neurology (Drs. Good, Mathias, and Quinn), Queen Square, London, UK; and Department of Neurology (Dr. Schwarz), University of Leipzig, Germany.
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
C. J. Mathias
From MRC Clinical Sciences Center and Division of Neuroscience (Drs. Gerhard, Banati, Goerres, Cagnin, Myers, Gunn, Turkheimer, Mathias, and Brooks), Faculty of Medicine, Imperial College, London, UK; Division of Nuclear Medicine (Dr. Goerres), University of Zürich, Switzerland; Department of Neurology and Psychiatry (Dr. Cagnin), University of Padua, Italy; Imaging Research Solutions Ltd. (Drs. Myers, Turkheimer, and Brooks), Hammersmith Hospital, London, UK; McConnell Brain Imaging Center (Dr. Gunn), Montreal Neurological Institute, Montreal, Canada; Institute of Neurology (Drs. Good, Mathias, and Quinn), Queen Square, London, UK; and Department of Neurology (Dr. Schwarz), University of Leipzig, Germany.
MD DSc
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
N. Quinn
From MRC Clinical Sciences Center and Division of Neuroscience (Drs. Gerhard, Banati, Goerres, Cagnin, Myers, Gunn, Turkheimer, Mathias, and Brooks), Faculty of Medicine, Imperial College, London, UK; Division of Nuclear Medicine (Dr. Goerres), University of Zürich, Switzerland; Department of Neurology and Psychiatry (Dr. Cagnin), University of Padua, Italy; Imaging Research Solutions Ltd. (Drs. Myers, Turkheimer, and Brooks), Hammersmith Hospital, London, UK; McConnell Brain Imaging Center (Dr. Gunn), Montreal Neurological Institute, Montreal, Canada; Institute of Neurology (Drs. Good, Mathias, and Quinn), Queen Square, London, UK; and Department of Neurology (Dr. Schwarz), University of Leipzig, Germany.
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
J. Schwarz
From MRC Clinical Sciences Center and Division of Neuroscience (Drs. Gerhard, Banati, Goerres, Cagnin, Myers, Gunn, Turkheimer, Mathias, and Brooks), Faculty of Medicine, Imperial College, London, UK; Division of Nuclear Medicine (Dr. Goerres), University of Zürich, Switzerland; Department of Neurology and Psychiatry (Dr. Cagnin), University of Padua, Italy; Imaging Research Solutions Ltd. (Drs. Myers, Turkheimer, and Brooks), Hammersmith Hospital, London, UK; McConnell Brain Imaging Center (Dr. Gunn), Montreal Neurological Institute, Montreal, Canada; Institute of Neurology (Drs. Good, Mathias, and Quinn), Queen Square, London, UK; and Department of Neurology (Dr. Schwarz), University of Leipzig, Germany.
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
D. J. Brooks
From MRC Clinical Sciences Center and Division of Neuroscience (Drs. Gerhard, Banati, Goerres, Cagnin, Myers, Gunn, Turkheimer, Mathias, and Brooks), Faculty of Medicine, Imperial College, London, UK; Division of Nuclear Medicine (Dr. Goerres), University of Zürich, Switzerland; Department of Neurology and Psychiatry (Dr. Cagnin), University of Padua, Italy; Imaging Research Solutions Ltd. (Drs. Myers, Turkheimer, and Brooks), Hammersmith Hospital, London, UK; McConnell Brain Imaging Center (Dr. Gunn), Montreal Neurological Institute, Montreal, Canada; Institute of Neurology (Drs. Good, Mathias, and Quinn), Queen Square, London, UK; and Department of Neurology (Dr. Schwarz), University of Leipzig, Germany.
MD DSc
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Full PDF
Citation
[11C](R)-PK11195 PET imaging of microglial activation in multiple system atrophy
A. Gerhard, R. B. Banati, G. B. Goerres, A. Cagnin, R. Myers, R. N. Gunn, F. Turkheimer, C. D. Good, C. J. Mathias, N. Quinn, J. Schwarz, D. J. Brooks
Neurology Sep 2003, 61 (5) 686-689; DOI: 10.1212/01.WNL.0000078192.95645.E6

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Permissions

Make Comment

See Comments

Downloads
777

Share

  • Article
  • Figures & Data
  • Info & Disclosures
Loading

This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.

Abstract

Microglia, the brain’s intrinsic macrophages, bind (R)-PK11195 when activated by neuronal injury. The authors used [11C](R)-PK11195 PET to localize in vivo microglial activation in patients with multiple system atrophy (MSA). Increased [11C](R)-PK11195 binding was primarily found in the dorsolateral prefrontal cortex, putamen, pallidum, pons, and substantia nigra, reflecting the known distribution of neuropathologic changes in MSA. Providing an indicator of disease activity, [11C](R)-PK11195 PET can thus be used to characterize the in vivo neuropathology of MSA.

  • Received July 8, 2002.
  • Accepted in final form April 21, 2003.
View Full Text

AAN Members

We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.

Google Safari Microsoft Edge Firefox

Click here to login

AAN Non-Member Subscribers

Click here to login

Purchase access

For assistance, please contact:
AAN Members (800) 879-1960 or (612) 928-6000 (International)
Non-AAN Member subscribers (800) 638-3030 or (301) 223-2300 option 3, select 1 (international)

Sign Up
Information on how to subscribe to Neurology and Neurology: Clinical Practice can be found here 

Purchase
Individual access to articles is available through the Add to Cart option on the article page.  Access for 1 day (from the computer you are currently using) is US$ 39.00.  Pay-per-view content is for the use of the payee only, and content may not be further distributed by print or electronic means.  The payee may view, download, and/or print the article for his/her personal, scholarly, research, and educational use.  Distributing copies (electronic or otherwise) of the article is not allowed.

Letters: Rapid online correspondence

No comments have been published for this article.
Comment

REQUIREMENTS

You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.

Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.

Submission specifications:

  • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
  • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
  • Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
  • Article
    • Abstract
    • Methods.
    • Results.
    • Discussion.
    • Acknowledgments
    • References
  • Figures & Data
  • Info & Disclosures
Advertisement

Differentiating Multiple Sclerosis From AQP4-Neuromyelitis Optica Spectrum Disorder and MOG-Antibody Disease With Imaging

Dr. Ann Yeh and Dr. Daniela Castillo Villagrán

► Watch

Related Articles

  • No related articles found.

Topics Discussed

  • PET
  • Multiple system atrophy

Alert Me

  • Alert me when eletters are published

Recommended articles

  • Articles
    Microglial activation correlates with severity in Huntington disease
    A clinical and PET study
    N. Pavese, A. Gerhard, Y. F. Tai et al.
    Neurology, June 12, 2006
  • Article
    [11C]PK11195 binding in Alzheimer disease and progressive supranuclear palsy
    Luca Passamonti, Patricia Vázquez Rodríguez, Young T. Hong et al.
    Neurology, April 27, 2018
  • Brief Communications
    [11C](R)-PK11195 positron emission tomography imaging of activated microglia in vivo in Rasmussen’s encephalitis
    R.B. Banati, G.W. Goerres, R. Myers et al.
    Neurology, December 01, 1999
  • Articles
    Microglial activation and amyloid deposition in mild cognitive impairment
    A PET study
    A. Okello, P. Edison, H. A. Archer et al.
    Neurology, January 02, 2009
Neurology: 101 (11)

Articles

  • Ahead of Print
  • Current Issue
  • Past Issues
  • Popular Articles
  • Translations

About

  • About the Journals
  • Ethics Policies
  • Editors & Editorial Board
  • Contact Us
  • Advertise

Submit

  • Author Center
  • Submit a Manuscript
  • Information for Reviewers
  • AAN Guidelines
  • Permissions

Subscribers

  • Subscribe
  • Activate a Subscription
  • Sign up for eAlerts
  • RSS Feed
Site Logo
  • Visit neurology Template on Facebook
  • Follow neurology Template on Twitter
  • Visit Neurology on YouTube
  • Neurology
  • Neurology: Clinical Practice
  • Neurology: Education
  • Neurology: Genetics
  • Neurology: Neuroimmunology & Neuroinflammation
  • AAN.com
  • AANnews
  • Continuum
  • Brain & Life
  • Neurology Today

Wolters Kluwer Logo

Neurology | Print ISSN:0028-3878
Online ISSN:1526-632X

© 2023 American Academy of Neurology

  • Privacy Policy
  • Feedback
  • Advertise